BRPI0408516A - composições autoemulsificantes, métodos de uso e preparação - Google Patents

composições autoemulsificantes, métodos de uso e preparação

Info

Publication number
BRPI0408516A
BRPI0408516A BRPI0408516-7A BRPI0408516A BRPI0408516A BR PI0408516 A BRPI0408516 A BR PI0408516A BR PI0408516 A BRPI0408516 A BR PI0408516A BR PI0408516 A BRPI0408516 A BR PI0408516A
Authority
BR
Brazil
Prior art keywords
self
emulsifying compositions
preparation
compositions
prepared
Prior art date
Application number
BRPI0408516-7A
Other languages
English (en)
Inventor
Zhi-Jian Yu
Stanley W Huth
Lauren L Crawford
James N Cook
Original Assignee
Advanced Medical Optics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced Medical Optics Inc filed Critical Advanced Medical Optics Inc
Publication of BRPI0408516A publication Critical patent/BRPI0408516A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Eyeglasses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Colloid Chemistry (AREA)

Abstract

"COMPOSIçõES AUTOEMULSIFICANTES, MéTODOS DE USO E PREPARAçãO". Preparação de composições autoemulsificantes que são preparadas sem homogeneização mecânica é descrita. Essas composições autoemulsificantes são preparadas usando um ou dois tensoativos. Isso prove a vantagem de uma razão de peso baixa de componente emulsificante para componente oleoso e menos preocupações com toxidez química, resultando em vantagens de conforto e segurança sobre as emulsões empregando mais de dois emulsificantes. Conseqüentemente, as composições autoemulsificantes descritas são idealmente adequadas para aplicações oftálmicas incluindo administração de agentes terapêuticos ao olho. Composições autoemulsificantes preparadas através do método descrito são descritas.
BRPI0408516-7A 2003-03-18 2004-03-17 composições autoemulsificantes, métodos de uso e preparação BRPI0408516A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/392,375 US20040185068A1 (en) 2003-03-18 2003-03-18 Self-emulsifying compositions, methods of use and preparation
PCT/US2004/008076 WO2004082625A2 (en) 2003-03-18 2004-03-17 Self-emulsifying compositions, methods of use and preparation

Publications (1)

Publication Number Publication Date
BRPI0408516A true BRPI0408516A (pt) 2006-03-07

Family

ID=32987875

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408516-7A BRPI0408516A (pt) 2003-03-18 2004-03-17 composições autoemulsificantes, métodos de uso e preparação

Country Status (8)

Country Link
US (2) US20040185068A1 (pt)
EP (1) EP1603607A2 (pt)
JP (1) JP2006526579A (pt)
CN (1) CN1791383A (pt)
AU (1) AU2004222295B2 (pt)
BR (1) BRPI0408516A (pt)
CA (1) CA2519300A1 (pt)
WO (1) WO2004082625A2 (pt)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8858961B2 (en) 2000-07-14 2014-10-14 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20050026924A1 (en) * 2000-07-14 2005-02-03 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
AU2011250793B2 (en) * 2000-07-14 2012-11-29 Allergan, Inc. Compositions containing alpha-2-adrenergic agonist components
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20060251685A1 (en) * 2003-03-18 2006-11-09 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with Omega-3 fatty acids for alleviating dry eye
JP5382973B2 (ja) * 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
JP5318850B2 (ja) * 2003-12-26 2013-10-16 ロート製薬株式会社 粘度低下が防止された組成物
JP5382972B2 (ja) * 2003-12-26 2014-01-08 ロート製薬株式会社 粘度低下が防止された組成物
DE602005020912D1 (de) * 2004-03-18 2010-06-10 Galderma Sa Ivermectin enthaltende creme
US7544671B2 (en) * 2004-05-07 2009-06-09 S.K. Pharmaceuticals, Inc. Stabilized hyaluronan preparations and related methods
US8288362B2 (en) * 2004-05-07 2012-10-16 S.K. Pharmaceuticals, Inc. Stabilized glycosaminoglycan preparations and related methods
BRPI0512864B8 (pt) * 2004-07-01 2021-05-25 Johnson & Johnson Vision Care composição oftálmica, uso de pelo menos um ácido graxo ômega-6 e pelo menos um ácido graxo ômega-3 e método para preparar a referida composição
US20070265341A1 (en) * 2004-07-01 2007-11-15 The Schepens Eye Research Institute Inc. Compositions and methods for treating eye disorders and conditions
JP4999304B2 (ja) * 2004-09-27 2012-08-15 ロート製薬株式会社 ヒアルロン酸又はその塩を含有する粘膜適用組成物
US9161905B2 (en) * 2005-01-12 2015-10-20 Ocular Research Of Boston, Inc. Dry eye treatment
US7297679B2 (en) * 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) * 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US8288348B2 (en) 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US7202209B2 (en) * 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20070087962A1 (en) * 2005-10-17 2007-04-19 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US20070138439A1 (en) * 2005-12-21 2007-06-21 3M Innovative Properties Company Denaturant for ethanol
US20070148127A1 (en) * 2005-12-22 2007-06-28 Heiler David J Antimicrobial ophthalmic treatment system and method
US7767217B2 (en) * 2006-03-14 2010-08-03 Foresight Biotherapeutics Ophthalmic compositions comprising povidone-iodine
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
WO2008120249A1 (en) 2007-03-30 2008-10-09 Sifi S.P.A. Pharmaceutical formulations based on apolar and polar lipids for ophthalmic use
EP1985298A1 (en) * 2007-04-24 2008-10-29 Azad Pharma AG Ophtalmic oil-in-water emulsions containing prostaglandins
US20110144010A1 (en) * 2007-06-01 2011-06-16 Novo Nordisk A/S Spontaneously Dispersible Preconcentrates Including a Peptide Drug in a Solid or Semisolid Carrier
US20090036404A1 (en) * 2007-08-02 2009-02-05 Macleod Steven K Ophthalmic compositions comprising a carboxyl-modified fructan or a salt thereof
WO2009084021A2 (en) * 2007-10-16 2009-07-09 Sun Pharma Advanced Research Company Limited Novel ophthalmic compositions
WO2009067734A1 (en) * 2007-11-28 2009-06-04 Commonwealth Scientific And Industrial Research Organisation Nanoemulsions
US20130059796A1 (en) * 2007-12-13 2013-03-07 Allergan, Inc Cyclosporin compositions
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
CN102037008B (zh) 2008-03-18 2016-08-31 诺沃-诺迪斯克有限公司 蛋白酶稳定化的、酰化胰岛素类似物
WO2010091362A2 (en) * 2009-02-06 2010-08-12 Mesh Therapeutics, Llc Topical formulations comprising ion channel modulators
US20100273730A1 (en) * 2009-04-27 2010-10-28 Innopharmax, Inc. Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof
US8496976B2 (en) 2009-06-05 2013-07-30 Allergan, Inc. Artificial tears and therapeutic uses
WO2011001951A1 (ja) * 2009-06-30 2011-01-06 ライオン株式会社 眼科用組成物
EP2488022B1 (en) 2009-10-16 2018-01-10 Mochida Pharmaceutical Co., Ltd. Compositions
CL2012001399A1 (es) 2009-12-03 2013-03-08 Novartis Ag Metodo para fabricar adyuvante para vacuna (emulsion aceite/agua con escualeno, polisorbato 80 y trioleato de sorbitan), que comprende (i) formar primera emulsion en homogenizador desde un contendor a otro para formar segunda emulsion, (ii) y microfluidizar primera emulsion para formar segunda emulsion.
JP5751678B2 (ja) * 2009-12-03 2015-07-22 ノバルティス アーゲー マイクロフルイダイゼーションのための相互作用チャンバおよび背圧チャンバの構成
DE102009056884B4 (de) 2009-12-03 2021-03-18 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
DE102009056883B4 (de) 2009-12-03 2012-08-16 Novartis Ag Impfstoff-Adjuvantien und verbesserte Verfahren zur Herstellung derselben
EP2506832B1 (en) 2009-12-03 2014-02-26 Novartis AG Hydrophilic filtration during manufacture of vaccine adjuvants
RS52748B (sr) 2009-12-03 2013-08-30 Novartis Ag Cirkulacija komponenti tokom homogenizacije emulzija
IT1404931B1 (it) * 2010-06-11 2013-12-09 Medivis S R L Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .
WO2012041910A1 (de) 2010-10-01 2012-04-05 Elektra Management S.R.O. Lösung von guanidinium-verbindungen, verfahren unter einsatz dieser lösung sowie deren verwendung
CA2858574C (en) * 2011-12-07 2017-05-30 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9481721B2 (en) 2012-04-11 2016-11-01 Novo Nordisk A/S Insulin formulations
US9132106B2 (en) * 2013-03-14 2015-09-15 Abbott Medical Optics Inc. Synergistic ophthalmic compositions for disinfecting contact lenses
US9089562B2 (en) * 2013-08-28 2015-07-28 Presbyopia Therapies Llc Compositions and methods for the treatment of presbyopia
KR20170120161A (ko) * 2015-03-05 2017-10-30 알러간, 인코포레이티드 안과용 약물 전달을 위한 자가-유화 약물 전달 시스템(sedds)
US20200397727A1 (en) * 2016-10-12 2020-12-24 Ps Therapies Ltd Drug vehicle compositions and methods of use thereof
US20230285286A1 (en) * 2016-10-12 2023-09-14 Ps Therapy, Inc. Drug vehicle compositions and methods of use thereof
US11583496B2 (en) * 2016-10-12 2023-02-21 PS Therapy Inc. Drug vehicle compositions and methods of use thereof
CN110114119B (zh) * 2016-10-12 2022-05-31 Ps治疗有限公司 人工泪液、隐形眼镜和药物载体组合物及其使用方法
US20190262290A1 (en) * 2016-10-12 2019-08-29 Ps Therapies Ltd Drug vehicle compositions and methods of use thereof
TWI700091B (zh) 2016-12-16 2020-08-01 丹麥商諾佛 儂迪克股份有限公司 含胰島素醫藥組成物
AU2019261437B2 (en) 2018-04-27 2024-11-07 Allergan, Inc. Sodium chlorite compositions with enhanced anti-microbial efficacy and reduced toxicity
WO2020071297A1 (ja) * 2018-10-01 2020-04-09 千寿製薬株式会社 水性液剤
WO2021262184A1 (en) * 2020-06-26 2021-12-30 Renden Tashiro Disinfectant solution and article coated with disinfectant solution
CN112842936A (zh) * 2021-03-15 2021-05-28 傅博 一种眼部清洁液及其制备方法
WO2025108987A1 (en) * 2023-11-21 2025-05-30 Bausch + Lomb Ireland Limited Compositions and methods for treating eyetear film deficiency and redeye

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4818614A (en) * 1985-07-29 1989-04-04 Shiseido Company Ltd. Modified powder
KR920003601B1 (ko) * 1987-09-03 1992-05-04 유니버시티 어브 죠지아 리서취 화운데이션 인코포레이티드 점안 싸이클로스포린(cyclosporin)의 조성물
US5407683A (en) * 1990-06-01 1995-04-18 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
DE4206154A1 (de) * 1992-02-28 1993-09-02 Wella Ag Verfahren zur gewinnung von apfelwachs, durch diese verfahren erhaeltliches apfelwachs sowie apfelwachshaltige kosmetische mittel
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
IL103907A0 (en) * 1992-11-27 1993-04-04 Pharmos Corp Ophthalmic compositions
EP0656779B1 (en) * 1992-08-28 2000-04-12 Pharmos Corporation Submicron emulsions as ocular drug delivery vehicles
EP0596304B1 (de) * 1992-10-31 1998-04-01 Th. Goldschmidt AG Kosmetische oder pharmazeutische Zubereitungen
GB9514878D0 (en) * 1995-07-20 1995-09-20 Danbiosyst Uk Vitamin E as a solubilizer for drugs contained in lipid vehicles
US5679327A (en) * 1995-08-25 1997-10-21 Johnson Products Co., Inc. Hair straightening emulsion
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
NZ502567A (en) * 1997-07-29 2002-03-28 Upjohn Co Self-emulsifying formulation for lipophilic compounds containing a pyranone and a mixture of monoglycerides and diglycerides
ATE265847T1 (de) * 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen
FR2767069B1 (fr) * 1997-08-08 1999-09-17 Ard Sa Composition emulsionnante a base de polyglycosides et d'alcool gras
US6979456B1 (en) * 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU3843999A (en) * 1998-05-07 1999-11-23 Elan Corporation, Plc Solvent/cosolvent free microemulsion and emulsion preconcentrate drug delivery systems
FR2787027B1 (fr) * 1998-12-14 2001-01-12 Oreal Nanoemulsion a base d'esters gras de sucre ou d'ethers gras de sucre et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6506394B1 (en) * 1999-06-30 2003-01-14 Kimberly-Clark Worldwide, Inc. Delivery of a botanical extract to a treated substrate for transfer to skin
AU7638300A (en) * 1999-10-20 2001-04-30 Vesifact Ag Microemulsion preconcentrates and microemulsions
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
WO2001097784A1 (en) * 2000-06-23 2001-12-27 Takeda Chemical Industries, Ltd. Process for producing phospholipid-containing drugs
FR2819427B1 (fr) * 2001-01-18 2003-04-11 Oreal Nanoemulsion translucide, son procede de fabrication et ses utilisations dans les domaines cosmetique, dermatologique et/ou ophtalmologique
US7235230B2 (en) * 2001-10-24 2007-06-26 Clariant Finance (Bvi) Limited Leave-on compositions for personal care
US6656460B2 (en) * 2001-11-01 2003-12-02 Yissum Research Development Method and composition for dry eye treatment
AU2002343555A1 (en) * 2001-11-14 2003-05-26 Texas Tech University Eutectic-based self-nanoemulsified drug delivery system
US20030165545A1 (en) * 2002-01-30 2003-09-04 Allergan, Inc. Ophthalmic compositions including oil-in-water emulsions, and methods for making and using same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation

Also Published As

Publication number Publication date
WO2004082625A2 (en) 2004-09-30
WO2004082625A3 (en) 2004-11-18
AU2004222295A1 (en) 2004-09-30
EP1603607A2 (en) 2005-12-14
CA2519300A1 (en) 2004-09-30
AU2004222295B2 (en) 2008-07-17
CN1791383A (zh) 2006-06-21
US20040185068A1 (en) 2004-09-23
US20040191284A1 (en) 2004-09-30
JP2006526579A (ja) 2006-11-24

Similar Documents

Publication Publication Date Title
BRPI0408516A (pt) composições autoemulsificantes, métodos de uso e preparação
AU2007278141B2 (en) Compositions containing quaternary ammonium compounds
ES2525238T3 (es) Método para preparar emulsiones aceite-en-agua a partir de concentrados de geles autoemulsionantes
BRPI0417287A (pt) espuma oleosa para uso farmacêutico e cosmético
BR9509897A (pt) Composição de liberação controlada para um material biologicamente ativo uso da mesma processo para preparação de uma composição de liberação controlada e para administração a mamíferos especialmente ao homem de um material biologicamante ativo e composição para uso como uma composição medicinal nasal
BR0111136A (pt) Composição farmacêutica estéril, uso da mesma, e, método para melhorar a sobrevivência de um paciente doente em estado crìtico
EA200901161A1 (ru) Вакцина против гриппа в виде эмульсии типа "масло в воде"
BRPI0519142A2 (pt) espuma de bomba alcoàlica
EA201001439A1 (ru) Трехфазная эмульсия (варианты), способ ее приготовления и нанесения
DE602004020745D1 (de) Schaumerzeugender kit enthaltend einen schaumspender und eine hoch viskose zusammensetzung
ATE380541T1 (de) Herstellung von vitaminemulsionen und konzentrate davon
BR0311777A (pt) Composição de vesìcula meningocócica multivalente, vacina para o tratamento de doença neisserial, métodos para fabricação de composição de vesìcula meningocócica multivalente e para prevenção ou tratamento de doença neisserial, e, uso de uma quantidade imunologicamente eficaz da vacina
BR0202483A (pt) Composição para reter ingredientes ativos, de cuidado pessoal dermicante não irritante resistente a água e processos para reter um ingrediente ativo em uma composição, e, para tratar a pele de mamìferos
AR125413A2 (es) Composiciones herbicidas
BRPI0500402A (pt) microemulsão
BR0309421A (pt) Composições de proteìna associada com corpo oleoso e métodos de uso destas para reduzir o risco de doença cardiovascular
BR0210303A (pt) Composição perfumante livre de álcool, processo para a preparação da mesma, e, uso de um óleo fluorado volátil
EP2014689A3 (fr) Nouveaux épaississants cationiques, procédé pour leur préparation et composition en contenant
Crocenzi et al. Silibinin prevents cholestasis-associated retrieval of the bile salt export pump, Bsep, in isolated rat hepatocyte couplets: possible involvement of cAMP
BR0213962A (pt) Composição tensoativa incluindo etoxilato de cnsl
BRPI0517420A (pt) composições de limpeza compreendendo emulsificantes poliméricos e métodos para utilização da mesma
JPS6416716A (en) Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein
BR0317523A (pt) Processo para a preparação de formulações farmacêuticas de combinação utilizando fluidos supercrìticos
BR0012796A (pt) Composição de cisplatina farmacêutica estéril como uma emulsão de óleo-em-água dotada de baixa toxicidade para administração parenteral e processo para a preparação da mesma
BRPI0410624A (pt) emulsão água-em-óleo transparente

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.